Cancer trials: Search results
Results: 145 items found. Showing page 2 of 6.
Refine results
Biobanking of Prostate Cancer Patients in the Post-Therapy Setting
Trial short name: Biobank Post-Treatment
Cancer type: Genitourinary
Cancer location: Genitourinary
Disease stage: Early Cancer
Trial phase:
Biomarker Discovery Project in High Grade Serous Ovarian Cancer
Trial short name: BioDIVA
Cancer type: Gynecology
Cancer location: Gynecology
Disease stage: Early Cancer
Trial phase: Other
ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions (ELEMENT-MDS)
Trial short name: BMS 025 ELEMENT
Cancer type: Blood Related
Cancer location: Blood Related
Disease stage: Early Cancer
Trial phase: Phase 3
A PHASE I-III, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF MULTIPLE THERAPIES IN COHORTS OF PATIENTS SELECTED ACCORDING TO BIOMARKER STATUS, WITH LOCALLY ADVANCED, UNRESECTABLE, STAGE III NON-SMALL CELL LUNG CANCER
Trial short name: BO42777
Cancer type: Lung
Cancer location: Lung
Disease stage: Early Cancer
Trial phase: Phase 3
A Phase III Prospective Double Blind Placebo Controlled Randomized Study of Adjuvant MEDI4736 in Completely Resected Non-Small Cell Lung Cancer
Trial short name: BR.31
Cancer type: Lung
Cancer location: Lung
Disease stage: Early and Advanced Cancer
Trial phase: Phase 3
For All HDR and LDR Brachytherapy Patients
Trial short name: Brachy Biobanking
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Other
Trial phase: Other
Parallel Prospective Observational Cohorts Evaluating Stereotactic Radiosurgery Alone (SRS) and Whole Brain Radiotherapy (WBRT) plus SRS for patients with 5 to 30 Brain metastases
Trial short name: Brain Mets
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Phase 3
Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia (BRAWM)
Trial short name: Brawm
Cancer type: Blood Related
Cancer location: Blood Related
Disease stage: Early Cancer
Trial phase:
MRI BRAIN SURVEILLANCE ALONE VERSUS MRI SURVEILLANCE AND PROPHYLACTIC CRANIAL IRRADIATION (PCI): A RANDOMIZED PHASE III TRIAL IN SMALL-CELL LUNG CANCER (MAVERICK)
Trial short name: BRC.8
Cancer type: Lung
Cancer location: Lung
Disease stage: Early Cancer
Trial phase: Phase 3
"AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 3 STUDY OF FIRST-LINE ENCORAFENIB PLUS CETUXIMAB WITH OR WITHOUT CHEMOTHERAPY VERSUS STANDARD OF CARE THERAPY WITH A SAFETY LEAD-IN OF ENCORAFENIB AND CETUXIMAB PLUS CHEMOTHERAPY IN PARTICIPANTS WITH METASTATIC BRAF V600E-MUTANT COLORECTAL CANCER"
Trial short name: BREAKWATER
Cancer type: Gastrointestinal
Cancer location: Gastrointestinal
Disease stage: Early Cancer
Trial phase: Phase 3
RNA Disruption Assay (RDA) - Breast cancer Response EValuation for Individualized TherapY
Trial short name: BREVITY
Cancer type: Breast
Cancer location: Breast
Disease stage: Early and Advanced Cancer
Trial phase: Other
Routine MRI screening versus symptom-directed screening for brain metastases among patients with triple negative and HER2+ metastatic breast cancer (MBC): A single-centre randomized phase II pilot study
Trial short name: BrM Screening
Cancer type: Breast
Cancer location: Breast
Disease stage: Advanced Cancer
Trial phase: Phase 2
TFRI Canadian Colorectal Cancer Consortium (C4): Molecular Screening in Patients with Colorectal Cancer and Their Family-Members
Trial short name: C4
Cancer type: Gastrointestinal
Cancer location: Colorectal
Disease stage: Early and Advanced Cancer
Trial phase: Other
A Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib + Docetaxel Versus Placebo + Docetaxel as Treatment for Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
Trial short name: CAPItello-280
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Early Cancer
Trial phase: Phase 3
A Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib+Abiraterone Versus Placebo+Abiraterone as Treatment for Patients With DeNovo Metastatic Hormone-Sensitive Prostate Cancer Characterised by PTEN Deficiency.
Trial short name: CAPItello-281
Cancer type: Genitourinary
Cancer location: Genitourinary
Disease stage: Early Cancer
Trial phase: Phase 3
A PHASE II STUDY OF 177LUTETIUM-DOTATATE RETREATMENT VS. EVEROLIMUS IN METASTATIC/UNRESECTABLE MIDGUT NET
Trial short name: CCTG NE.1
Cancer type: Neuroendocrine
Cancer location: Neuroendocrine
Disease stage: Early Cancer
Trial phase: Phase 2
Imaging biomarker for differentiating of radiation necrosis from tumour progression in brain metastasis treated with stereotactic radiosurgery
Trial short name: CEST Necrosis
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Other
Comprehensive Health Assessment for my cancer treatment plan: Field Validation of a geriatric assessment tool for cancer patients
Trial short name: CHAMP-F
Cancer type: Genitourinary
Cancer location: Genitourinary
Disease stage: Early Cancer
Trial phase:
Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications
Trial short name: CHIP
Cancer type: Blood Related
Cancer location: Lymphoma
Disease stage: Early Cancer
Trial phase: Other
Canadian Kidney Cancer Information System
Trial short name: CKCIS DATABASE
Cancer type: Genitourinary
Cancer location: Kidney
Disease stage: Other
Trial phase: Other
Tucatinib With Brain and/or Spinal XRT in Patients With HER2+ Metastatic Breast Cancer and LMD
Trial short name: CLIMB LMD
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Phase 2
A Randomized, Parallel Group Study to Evaluate the Safety, Pharmacokinetics, and Dose Response of Paltusotine Treatment in Subjects with Carcinoid Syndrome
Trial short name: CRN00808-11
Cancer type: Neuroendocrine
Cancer location: Neuroendocrine
Disease stage: Early Cancer
Trial phase: Phase 2
CROSS- CRPC Oligometastases treated with SBRT plus Systemic therapy
Trial short name: CROSS
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Early Cancer
Trial phase:
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
Trial short name: CYCLONE 3
Cancer type: Genitourinary
Cancer location: Genitourinary
Disease stage: Early Cancer
Trial phase: Phase 3
Cytoreductive Stereotactic Hypofractionated Radiotherapy With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer
Trial short name: CYTOSHRINK
Cancer type: Genitourinary
Cancer location: Kidney
Disease stage: Early Cancer
Trial phase: Phase 2